Foetal and neonatal alloimmune thrombocytopaenia

Orphanet Journal of Rare Diseases

Volumn 1, Issue 1, 2006, Pages

  Kaplan, Cecile ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; THROMBOCYTE ANTIGEN;

BLOOD; FEMALE; FETOMATERNAL TRANSFUSION; FETUS DISEASE; HUMAN; IMMUNOLOGY; NEWBORN; NEWBORN DISEASE; PATHOLOGY; PREGNANCY; REVIEW; THROMBOCYTOPENIA;

ANTIGENS, HUMAN PLATELET; AUTOANTIBODIES; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MATERNAL-FETAL EXCHANGE; PREGNANCY; THROMBOCYTOPENIA;

EID: 34248209254     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-1-39     Document Type: Review

References (44)

1. Platelet and leukocyte isoantigens and their antibodies. Serologic, physiologic and clinical studies. NR Shulman VJ Marder MC Hiller EM Collier, Progress in Hematology New-York: Grune and Stratton, Moore CV, Brown EB, 4 1964 222 304 14272799
2. Management of fetal and neonatal alloimmune thrombocytopenia. C Kaplan F Forestier F Daffos G Tchernia A Waters, Transfu Med Rev 1996 10 233 240 10.1016/S0887-7963(96)80062-9
3. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group. I Durand-Zaleski N Schlegel C Blum-Boisgard S Uzan M Dreyfus C Kaplan, Am J Perinatol 1996 13 423 431 8960612
4. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PLA1, Zwa) as determined by antenatal screening. LM Williamson G Hackett J Rennie CR Palmer C Maciver R Hadfield D Hughes S Jobson WH Ouwehand, Blood 1998 92 2280 2287 9746765
5. Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. M Dreyfus C Kaplan E Verdy N Schlegel I Durand-Zaleski G Tchernia, Blood 1997 89 4402 4406 9192764
6. Management of alloimmune thrombocytopenia in the fetus and neonate. AH Waters M Murphy H Hambley K Nicolaides, Clinical and Basic Science Aspects of Immunohematology Arlington, VA: Amer Assn of Blood Banks, Sandra Taddie Nance ST, 1991 155 177
7. Recurrent intracranial haemorrhages in utero in an infant with alloimmune thrombocytopenia. Case report. LS de Vries J Connell GM Bydder LMS Dubowitz CH Rodeck RS Mibashan AH Waters, Br J Obstet Gynaecol 1988 95 299 302 3285884
8. Very early intracranial haemorrhage in alloimmune fetal thrombocytopenia. Y Giovangrandi F Daffos C Kaplan F Forestier J Mac Alleese M Moirot, Lancet 1990 336 310 10.1016/0140-6736(90)91842-X 1973993
9. Anti-HPA-3a induces severe neonatal alloimmune thrombocytopenia. J Glade-Bender JG McFarland C Kaplan L Porcelijn JB Bussel, J Pediatr 2001 138 862 867 10.1067/mpd.2001.114029 11391330
10. HPA-5b (Bra) neonatal alloimmune thrombocytopenia: Clinical and immunological analysis of 39 cases. C Kaplan MC Morel-Kopp H Kroll V Kiefel N Schlegel N Chesnel C Mueller-Eckhardt, Br J Haematol 1991 78 425 429 1873226
11. Antenatal PLA1 typing and detection of GP IIb-IIIa complex. C Kaplan C Patereau MF Reznikoff-Etievant JY Muller Y Dumez A Kesseler, Br J Haematol 1985 60 586 588 3160384
12. Determination of platelet antigens and glycoproteins in the human fetus. Y Gruel B Boizard F Daffos F Forestier J Caen JL Wautier, Blood 1986 68 488 492 2425870
13. Prenatal treatment of alloimmune thrombocytopenia. F Daffos F Forestier JY Muller MF Reznikoff-Etievant B Habibi M Capella-Pavlosky P Maigret C Kaplan, Lancet 1984 2 632 10.1016/S0140-6736(84)90614-7 6147656
14. Maternal anti-HLA antibodies and neonatal thrombocytopenia. R Sharon A Amar, Lancet 1981 1 1313 10.1016/S0140-6736(81)92481-8 6112624
15. Association of neonatal thrombocytopenia and maternal anti-HLA antibodies. N Koyama Y Ohama K Kaneko Y Itakura T Nakamura N Koyama Y Ohama K Kaneko Y Itakura T Nakamura, Acta Paediatr Jpn 1991 33 71 76 1853716
16. Eleven human platelet systems studied in the Vietnamese and Ma'ohis Polynesian populations. L Halle KH Bach C Martageix F Bianchi T Lê T Kim MC Morel-Kopp J Soulier C Tetaria C Kaplan, Tissue Antigens 2004 63 34 40 10.1111/j.1399-0039.2004.00149.x 14651521
17. HPA polymorphism in sub-Saharan African populations: Beninese, Cameroonians, Congolese, and Pygmies. L Halle A Bigot G Mulen-Imandy K M'Bayo G Jaeger L Anani C Martageix F Bianchi E Julien C Kaplan, Tissue Antigens 2005 65 295 298 10.1111/j.1399-0039.2005.00360.x 15730528
18. Nomenclature of platelet specific antigens. AE von dem Borne F Decary, Br J Haematol 1990 74 239 240
19. Nomenclature of human platelet alloantigens. AE von dem Borne C Kaplan R Minchinton, Blood 1995 85 1409 1410 7858275
20. Nomenclature of human platelet antigens. P Metcalfe NA Watkins WH Ouwehand C Kaplan P Newman R Kekomäki M de Haas R Aster Y Shibata J Smith V Kiefel S Santoso, Vox Sang 2003 85 240 245 10.1046/j.1423-0410.2003.00331.x 14516468
21. 348 cases of suspected neonatal alloimmune thrombocytopenia. C Mueller-Eckhardt V Kiefel A Grubert H Kroll M Weisheit S Schmidt G Mueller-Eckhardt S Santoso, Lancet 1989 1 363 366 10.1016/S0140-6736(89)91733-9 2563515
22. A functional platelet fibrinogen receptor with a deletion in the cysteine-rich repeat region of the beta(3) integrin: the Oe(a) alloantigen in neonatal alloimmune thrombocytopenia. S Santoso V Kiefel IG Richter UJ Sachs A Rahman B Carl H Kroll, Blood 2002 99 1205 1214 10.1182/blood.V99.4.1205 11830467
23. A new platelet polymorphism Duv(a+), localized within the RGD binding domain of glycoprotein IIIa, is associated with neonatal thrombocytopenia. V Jallu M Meunier M Brement C Kaplan, Blood 2002 99 4449 4456 10.1182/blood.V99. 12.4449 12036875
24. Immunization against a low-frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of reference DNA and novel allele-specific cell lines expressing recombinant antigens. H Kroll J Yates S Santoso, Transfusion 2005 45 353 358 10.1111/j.1537-2995.2005.04218.x 15752152
25. Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max) is an important cause of neonatal alloimmune thrombocytopenia. JA Peterson SM Balthazor BR Curtis JG McFarland RH Aster, Transfusion 2005 45 1487 1495 16131382 10.1111/j.1537-2995.2005.00561.x
26. Anti-HPA-9bw (Maxa) feto-maternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy, report on 8 families. C Kaplan L Porcelijn P Vanlieferinghen E Julien F Bianchi C Martageix G Bertrand V Jallu, Transfusion 2005 45 1799 1803 10.1111/j.1537-2995.2005. 00606.x 16271107
27. HLA-DRw52a is involved in alloimmunization against PL-A1 antigen. N Valentin A Vergracht JD Bignon ML Cheneau D Blanchard C Kaplan MF Reznikoff-Etievant JY Muller, Hum Immunol 1990 27 73 79 10.1016/0198-8859(90) 90104-W 2298610
28. The alloimmune thrombocytopenias: neonatal alloimmune thrombocytopenic purpura and post-transfusion purpura. TJ Kunicki DS Beardsley, Progress in hemostasis and thrombosis Philadelphia: W.B. Saunders company, Coller BS, 9 1989 203 232
29. The immune response to the HPA-1a antigen: association with HLA-DRw52a. F Decary D L'Abbe L Tremblay P Chartrand F Decary D L'Abbe L Tremblay P Chartrand, Transfus Med 1991 1 55 62 9259828
30. Genetic susceptibility and anti-human platelet antigen 5b alloimmunization. Role of HLA class II and TAP genes. G Semana T Zazoun M Alizadeh MC Morel-Kopp B Genetet C Kaplan, Hum Immunol 1996 46 114 119 10.1016/0198-8859(96)00019-5 8727210
31. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet-reactive antibodies. V Kiefel S Santoso M Weisheit C Mueller-Eckhardt, Blood 1987 70 1722 1726 2445398
32. Clinical aspects and typing of platelet alloantigens. H Kroll V Kiefel S Santoso, Vox Sang 1998 74 345 354 9704466
33. Thrombocytopenia in childhood. C Kaplan M Dreyfus V Proulle G Tchernia, Platelets in thrombotic and non-thrombotic disorders: pathophysiology, pharmacology and therapeutics Cambridge: Cambridge University Press, Gresele P, Page CP, Vermylen J, Fuster V, 2002 556 568
34. Fetomaternal alloimmune thrombocytopenia presenting antenatally as hydrops fetalis. SJ Stanworth GA Hackett LM Williamson, Prenat Diagn 2001 21 423 424 10.1002/pd.84 11360291
35. Absent umbilical artery end-diastolic velocity in growth-restricted fetuses: a risk factor for neonatal thrombocytopenia. AA Baschat U Gembruch I Reiss L Gortner CP Weiner CR Harman, Obstet Gynecol 2000 96 162 166 10.1016/S0029-7844(00)00904-2 10908756
36. Neonatal platelet counts in fetal brain injury. LM Korst JP Phelan YM Wang MO Ahn LM Korst JP Phelan YM Wang MO Ahn, Am J Perinatol 1999 16 79 83 10355914
37. Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT). V Kiefel D Bassler H Kroll B Paes G Giers J Ditomasso H Alber M Berns B Wiebe EM Quenzel J Hoch A Greinacher, Blood 2006 107 3761 3763 10.1182/blood-2005-06-2235 16403916
38. Intravenous immunoglobulin in treatment of neonatal isoimmune thrombocytopenia. GV Massey NB McWilliams DG Mueller A Napolitano HM Maurer, J Pediatr 1987 111 133 135 10.1016/S0022-3476(87)80360-8 3598774
39. Current trends in neonatal alloimmune thrombocytopenia diagnosis and therapy. C Kaplan F Daffos F Forestier MC Morel N Chesnel G Tchernia, Platelet Immunology: Fundamental and Clinical Aspects Paris: John Libbey-Eurotex/ed. INSERM, Kaplan-Gouet C, Schlegel N, Salmon Ch, Mac Gregor J, 1991 267 278
40. Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. G Bertrand C Martageix V Jallu F Vitry C Kaplan, J Thromb Haemost 2006 4 628 637 10.1111/j.1538-7836.2006.01809.x 16460445
41. Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility. S Gaddipati RL Berkowitz AA Lembet R Lapinski JG McFarland JB Bussel, Am J Obstet Gynecol 2001 185 976 980 10.1067/mob.2001.117668 11641688
42. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. JE Birchall MF Murphy C Kaplan H Kroll European Fetomaternal Alloimmune Thrombocytopenia Study Group, Br J Haematol 2003 122 275 288 10.1046/j.1365-2141.2003.04408.x 12846898
43. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. R Rayment SJ Brunskill S Stanworth PW Soothill DJ Roberts MF Murphy, Cochrane Database Syst Rev 2005 1 CD004226 15674934
44. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. RL Berkowitz EA Kolb JG McFarland M Wissert A Primani M Lesser JB Bussel, Obstet Gynecol 2006 107 91 96 16394045